Brain Neoplasm: Clinical Trials

2 trials for Brain Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 2
Phase 11Terminated 1

Follow Brain Neoplasm: new trials by email Literature Review of Brain Neoplasm trials Research Report on Brain Neoplasm

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery
Cetuximab, Cetuximab-IRDye 800CW, Tumor resection - Brain Neoplasm, Malignant Glioma
Phase 1 / Phase 2TerminatedEben Rosenthal32016-10-012020-03-31
Temozolomide as a Prophylaxis Against Brain Recurrence in Participants With Metastatic Breast Cancer (P05225 AM2)
temozolomide - Breast Neoplasm, Brain Neoplasm
Phase 2TerminatedMerck Sharp & Dohme LLC62008-10-022017-06-14

Narrower conditions

Brain Neoplasms (2)  ·  Breast Neoplasms (1)  ·  Glioma (1)  ·  Neoplasms, Second Primary (1)

Broader conditions

Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Central Nervous System Neoplasms (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Nervous System Diseases (2)  ·  Nervous System Neoplasms (2)  ·  Breast Diseases (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Neoplasms, Neuroepithelial (1)  ·  Neuroectodermal Tumors (1)  ·  Skin Diseases (1)

Interventions

Antibodies, Monoclonal (1)  ·  Cetuximab (1)  ·  Temozolomide (1)  ·  Transurethral Resection of Bladder (1)

Sponsors

Eben Rosenthal (1)  ·  Merck Sharp & Dohme LLC (1)

Countries

United States (1)

Top investigators

Eben Rosenthal, MD (1)  ·  Gordon Li, MD (1)

NIH funding

P30CA124435 (1)